News and Events

Information Day on Progress in Alternative Methods in Toxicology and Biomedicine

CAAT Academy Returns After the Summer with Two Sessions 

Thomas Hartung Quoted in Article About TSCA

Video: New Approaches to Predict the Effects of Chemicals—Reportage from ECHA's Scientific WorkshopThomas Hartung is interviewed in the full video.

Pan-American Brings Nearly 150 Attendees to Baltimore from the Americas and Around the Globe


February 11-12, 2015
Johns Hopkins University, Baltimore, MD

December 15-17, 2014
2014 NIH common fund High-Risk High-Reward symposium
NIH campus, Bethesda, MD

September 29-30, 2014
EPA Research Triangle Park Campus, NC.
2nd ToxCast Data Summit organized by the US Environment Protection Agency

September 3-5, 2014
NIH, Bethesda, MD.
Adverse Outcome Pathways: From Research to Regulation, organized by the National Toxicology Program

August 24-28, 2014
Prague, Czech Republic.
9th World Congress on Alternatives and Animal Use in the Life Sciences

November 11-12, 2013
Mt. Washington Conference Center, Baltimore, MD. “Toxicometabolomics Workshop: Application of Metabolomics in Toxicology Research”

November 13, 2013
Bloomberg School of Public Health, Baltimore, MD. “Metabolomics Information Day”

November 14-15, 2013
Mt. Washington Conference Center, Baltimore, MD. “Workshop on Quality Assurance of Metabolomics”

September 25-27, 2013
Frontiers in Cell Toxicity Testing organized by the Scandinavian Society for Cell Toxicology SSCT (T. Hartung & M. Bouhfid) “Mapping the Human Toxome”: Metabolomics in Cell assay studies status and prospects and Adverse outcome approaches

August 10, 2013
The Gordon Research Seminar on the Cellular & Molecular Mechanisms of Toxicology, Andover, NH: (A. Kleensang) “Mapping the Human Toxome by ‘-omics’ Data for New Regulatory Tools.”

July 17, 2013
NIEHS Office of the Director seminar, (T. Hartung) "A Plan for Revolutionizing Toxicology Testing for the 21st Century"

May 29, 2013
TERA workshop Advances in Risk Assessment (webinar) (Thomas Hartung) “Pathway-Based Regulatory Toxicology and Alternatives to Animal Testing”

May 20, 2013
NIBSC, London, UK (T. Hartung) “From alternative methods to toxicology for the 21st century”

May 14, 2013
Organisation for Economic Co-operation and Development, (OECD) Paris
(T. Hartung) “The Human Toxome Project”

March 10-14, 2013
The Society of Toxicology (SOT) 52nd Annual Meeting, San Antonio, TX,
(L. Zhao) “Metabolomics Characterization of the Effects of Estradiol in Human Breast Cancer Cell Lines”

March 4-8, 2013
EU Science: European Parliament, Brussels. Global Challenges & Global Cooperation
(T. Hartung) “New Regulatory Science in System Toxicology: Is an Update Needed, What Would Be the Critical Elements and by When?”

January 26-27, 2013
International Conference of Alternatives to Animal Experimentation, Lisbon (M. Bouhifd) “'The human toxome project”


December 17, 2012
Italian regulatory authority (Istituto Superiore di Sanita) and the Italian Platform for Alternative Methods
(T. Hartung): “Alternative in vitro methods to characterize the role of Endocrine Active Substances (EASs) in hormone-targeted tissues”

December 13, 2012
European Parliament Intergroup for Animal Welfare, Strasbourg,
(T. Hartung) “The Human Toxome project and endocrine disruption testing”

November 25-26, 2012
COLAMA, 1st Latin American Congress of Alternative Methods to the Use of Animals in Education, Research and Industry, Rio de Janeiro, Brazil
(A. Kleensang): “Mapping the Human Toxome for new regulatory tools”

November 17, 2012
Turkish Society of Toxicology, Antalya
(T. Hartung): “Toward a pathway- based regulatory toxicology”

October 18, 2012
SOT FutureTox opening keynote, Arlington
(T. Hartung): “The need for a roadmap for using Tox21 methods in risk assessment”

October 16, 2012
European Society for Toxicology In Vitro, Lisbon
(T. Hartung): “The most important –omics is economics”

October 10, 2012
European Parliament, event hosted by MEPs Mario Pirillo and Teresa Riera Madurell “Advancing Safety Science and Health Research Under Horizon 2020 with Innovative, Non-Animal Tools,” Brussels
(M. Leist): “Mapping the Pathways of Toxicity in Humans. What are the Benefits?”

October 10, 2012
Workshop on “The Concept and Tools for Pathways of Toxicity” organized by CAAT, Baltimore.
Workshop on the Concept and Tools PoT.pdf

October 3, 2012
Safety Pharmacology Society, Phoenix
(T. Hartung): “Implementing the vision of toxicity testing for the 21st century”

September 24, 2012
EMBL-EBI Industry programme workshop on Systems Toxicology, Cambridge
(A. Kleensang): “The Human Toxome Project or Mapping the Human Toxome for new Regulatory Tools”

August 19, 2012
American Chemical Society, Philadelphia
(T. Hartung): “Mapping the Human Toxome for new regulatory tools”

June 25-28, 2012
International Conference of the Metabolomics Society, Washington DC
(L. Zhao) “Intracellular Metabolomic Study of Estradiol-induced effects in Human Breast Cancer Lines MCF-7”

June 11, 2012
AXLR8 conference, Berlin
(T. Hartung): “Pathways of Toxicity Mapping Center—PoToMaC”

May 17, 2012
Applied Pharmacology & Toxicology Conference, Baltimore
(T. Hartung): “Mapping Pathways of Toxicity—a perspective on the future of toxicity testing”

May 15, 2012
European Parliament, event hosted by MEP Vittorio Prodi, “Human Toxome Project’ a new European Horizon for Risk Assessment”, Brussels, (T.Hartung): “The Human Toxome Project”

March 1, 2012
Agilent workshop at the Society of Toxicology Annual Meeting, on knowledge-driven multi-omics integration for PoT research: policy and technology drivers.
 (T. Hartung): “Mapping the Human Toxome”